/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort
Event: ESC Congress 2018
Topic: Device Complications and Lead Extraction
Session: Device implantation : infection and other complications
The FLUTFIB Survey: procedural characteristics, oral anticoagulation management and concomitant atrial fibrillation in patients undergoing catheter ablation of typical atrial flutter
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Results (Catheter ablation /except atrial fibrillation)
Session: Catheter ablation - Results
